Avanos Medical, Inc. to Present at the 2023 Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Avanos Medical, Inc. (NYSE: AVNS) announced that Michael Greiner, CFO and Chief Transformation Officer, will participate in a fireside chat at the 2023 virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 22 at 9:45 a.m. ET. A webcast of the presentation will be available in the Investors section on Avanos' website and will be archived for later access. Avanos focuses on clinically superior medical devices, providing vital nutrition solutions and reducing opioid use during patient recovery. The company is headquartered in Alpharetta, Georgia, and holds leading market positions across its product categories.
- None.
- None.
A webcast of the conference presentation will be available on the Investors section of the
About
View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-2023-virtual-keybanc-capital-markets-life-sciences--medtech-investor-forum-301772828.html
SOURCE
FAQ
What date will Michael Greiner speak at the KeyBanc Capital Markets Forum?
How can I watch the Avanos Medical presentation?
What is Avanos Medical's focus in healthcare?
Where is Avanos Medical headquartered?